Latest News
I love writing guest articles and collaborating
See appearances for Asa's events and podcasts
Mar 17, 2022
Interview
Danielle Masterson
Stress: What can you claim on a product label?
Asa Waldstein and two top advertising attorneys share their tips and best practices for marketing stress supplements.
đˇStress-free rules Ivan Wasserman, Amin Talati Wasserman, LLP
đˇPooja's do's and don'ts Pooja Nair
đˇAsa's helpful hints Supplement Advisory Group
Mar 16, 2022
Press Mention
Julia Peterman
#NaturallyInformed Event Looks at Immune Health from All Angles
Asa Waldstein, Principal, Supplement Advisory Group, discussed the most recent info on FDA and FTCâs thinking regarding immune support in Communicating in-store and onlineâwhere are we now? âFDA is going back many years and citing multi-year-old social media posts in warning letters,â he shared. âOne cited a social media post from 2014, and they treat those the same way as new posts. Hashtags are also claims. âLikingâ a post is a claim. Replying to or reposting a customer comment on social media, thatâs a claim. All marketing is considered âlabelingâ.â That includes, he said, product reviews and testimonials; infographics; citing studies; blogs; and more.
Sep 21, 2021
Interview
Cait Curley and Asa Waldstein
Influencers and CBD: Be Careful What You Say
Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/
Apr 5, 2021
Interview
Asa Waldstein Interviewed
AHPA publishes Hemp Lexicon
The American Herbal Products Association (AHPA) has published a Hemp Lexicon intended to support the standardization of the terminology used in the cultivation, processing, manufacturing, and labeling of hemp and products derived from hemp as defined in U.S. federal law.
Dec 18, 2020
Interview
Josh Long
FTC targets CBD marketers in law enforcement sweep
According to a Federal Trade Commission official, settlements in a law enforcement sweep against CBD marketers send a "clear message" to the growing sector: "Donât make spurious health claims that are unsupported by medical science."



















